Searchable abstracts of presentations at key conferences in endocrinology

ea0016oc3.9 | Diabetes and obesity | ECE2008

Effect of baseline sample characteristics, comparator drug, co-interventions and rosiglitazone doses on the risk of myocardial infarction: multivariable lineal regression analysis

Sapunar Jorge , Munoz Sergio , Jimenez Marcela , Ortiz Eugenia

Nissen’s meta-analysis concluded that the use of Rosiglitazone (RSG) was associated with a significant increase in the risk of myocardial infarction. However, none of the analyzed studies took into account the cardiovascular events as primary outcomes, neither were controlled by cardiovascular risk factors.Objectives: 1. To know if there is an association between RSG myocardial infarction OR and the magnitude of the difference in baseline serum lipi...